The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Facial Defect
Interventions
DRUG

cephalexin

This consists of a single dose of cefazolin or, in penicillin allergic patients, clindamycin administered at the time of anesthesia administration prior to the surgical incision. In the cohort randomized to receive post-operative antibiotics, the first choice intervention will be oral cephalexin (500 mg, three times daily or four times daily, for one week). In patients who are penicillin or cephalosporin allergic, we will prescribe clindamycin (300 mg, three times daily or four times daily, for one week). Patients will be followed up within 2 to 6 weeks of surgery and outcome measures assessed. Patients will, again, be seen at 6 months and 1 year post-operatively for outcome assessment.

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER